SAMDaily.us | PRESOL | 68 | NanoBret cellular activity assay, for 26 compounds, against LATS1 and AKT

SAMDAILY.US - ISSUE OF JANUARY 09, 2021 SAM #6981
SOLICITATION NOTICE

68 -- NanoBret cellular activity assay, for 26 compounds, against LATS1 and AKT

Notice Date: 1/7/2021 9:44:30 AM
Notice Type: Combined Synopsis/Solicitation
NAICS: 325412 — Pharmaceutical Preparation Manufacturing
Contracting Office: NATIONAL INSTITUTES OF HEALTH NCATS BETHESDA MD 20892 USA
ZIP Code: 20892
Solicitation Number: 21-001345
Response Due: 1/17/2020 5:00:00 AM
Archive Date: 02/01/2020
Point of Contact: karen elmore, Phone: 3014350842
E-Mail Address: karen.elmore@nih.gov
(karen.elmore@nih.gov)
Description: This order provides for the testing of 26 compounds against the AKT1 and LATS1 compounds in a NanoBRET target Engagement Intracellular Kinase Assay. This testing will inform on kinase inhibitory activity in our compound series, and will facilitate further optimization and development of these AKT1 / LATS1 compounds as well as potential treatments.�
Web Link: SAM.gov Permalink
(https://beta.sam.gov/opp/179ca492298b4251a931463132f06c43/view)
Place of Performance: Address: Rockville, MD 20850, USA; Zip Code: 20850; Country: USA
Record: SN05887500-F 20210109/210107230123 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |